How to Buy Pelthos Therapeutics Stock
Pelthos Therapeutics Inc
Pelthos Therapeutics is a biotech company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker PTHS on the NYSEMKT exchange.
Pelthos Therapeutics stock last closed at $27.69, up 6.46% from the previous day, and has increased 161.23% in one year. It has overperformed other stocks in the Biotechnology industry by 1.56 percentage points. Pelthos Therapeutics stock is currently +207.67% from its 52-week low of $9.00, and -49% from its 52-week high of $54.29.
There are currently 3.48M PTHS shares outstanding. The market capitalization of PTHS is $96.24M. In the last 24 hours, 46,400 PTHS shares were traded.
How to Buy Pelthos Therapeutics Stock
Not sure how to invest in Pelthos Therapeutics stock? Here's how.
- Figure out where to buy Pelthos Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Pelthos Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Choose your payment method and add your details.
- Analyze Pelthos Therapeutics stock: The Pelthos Therapeutics ticker symbol is PTHS. Is Pelthos Therapeutics stock a good investment? Should you buy shares of PTHS? How do PTHS's underlying business fundamentals look? Do top analysts think Pelthos Therapeutics is a good buy? Why has PTHS's stock price moved recently? (Hint: Our stock research website can help you understand if PTHS is a good stock to buy).
- Execute your PTHS buy order: Decide if you will purchase PTHS shares at the current market price or use a limit order to purchase PTHS shares at a particular price.
- Get the latest scoop on your PTHS position: Create a watchlist to key updates about your investment in Pelthos Therapeutics shares.
Step 1: Figure out where to buy Pelthos Therapeutics stock
You will need an online brokerage account to access the NYSEMKT market and buy PTHS stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal information so you can buy PTHS today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to open your new trading account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've finished signing up on the highest rated stock app, you need to deposit funds:
Watch the tutorial below for more details depositing funds into your new investment account.
Step 4: Analyze Pelthos Therapeutics stock
Once you have figured out the best place to buy Pelthos Therapeutics stock, it's very important to evaluate their stock before you invest, so you actually comprehend the risk as well as the upside.
Pelthos Therapeutics stock at a glance
Pelthos Therapeutics Overview
WallStreetZen was built to help everyday investors do more accurate fundamental analysis.
You can see all of the due diligence checks on PTHS's stock page.
Is PTHS stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PTHS's fair value.
Using relative valuations metrics:
- PTHS may be undervalued based on its P/B ratio of 2.74x, relative to Biotechnology industry P/B ratio of 4.99x
You can access more valuation research on PTHS's stock here.
PTHS Financial Health Overview
Pros:
- There are more short-term assets than short-term liabilities on the PTHS balance sheet.
Cons:
- PTHS has $32.23M in cash and short term investments. This is not sufficient to cover its annual cash burn of $43.27M.
- PTHS has a relatively high debt to equity ratio of 3.14.
- PTHS has cash burn of 43274874. It does not have sufficient cash and short-term investments to cover this.
- There are more long-term liabilities than short-term assets on the PTHS balance sheet.
- PTHS profit margin has gone down from N/A to -186.2% in the past year.
Is Pelthos Therapeutics stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 6 sell side analysts who track PTHS, the consensus analyst rating on Pelthos Therapeutics is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Latest PTHS Analyst Recommendations
Thomas Flaten, a top 40% analyst from Lake Street initiates coverage on PTHS with a strong buy rating and announces their PTHS price target of $50.00, on Dec 3, 2025.
You can dive deeper into what analysts are projecting on the Pelthos Therapeutics stock forecast page.
PTHS Technical Indicators
Who is buying/selling PTHS?
In the last year, executives and large shareholders at PTHS have bought more shares than they have sold.
Ezra M. Friedberg, Director of PTHS, was the latest PTHS insider to sell. They sold $6,010.02 worth of PTHS shares on Apr 2, 2026.
Get more info about who owns PTHS stock here.
Can I rely on PTHS as an income stream?
No, Pelthos Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about PTHS?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your PTHS buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at an exact price, place a limit order.
Hit the Open button and your broker will execute the order.
If you require additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your PTHS position
Now that you own some PTHS stock, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to see the latest developments about your PTHS stock.
PTHS Feed
How to Buy Stock in Pelthos Therapeutics
To summarize, here are the 6 steps to buy stock in Pelthos Therapeutics:
- Figure out where to buy Pelthos Therapeutics stock
- Sign up for a brokerage account
- Put funds into your investment account
- Analyze Pelthos Therapeutics stock
- Execute your PTHS buy order
- Get the latest scoop on your PTHS position
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Pelthos Therapeutics, hit the button below to create your watchlist.
More Articles You May Find Useful
- Where to buy Apple stock
- How to purchase Walmart stock online
- How to purchase Disney shares
- How to purchase Amazon stock online
- Where to buy GOOGL shares
- How to purchase shares in Berkshire Hathaway
- How to purchase Tesla stock online
- How to buy stocks online
- How to purchase Pfizer stock
- How to purchase stock in NFLX
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.